Market Cap 3.62B 963M 847M 787M 724M 1.36B 93.29B 1.38B 9.41B 3.67B 45.5B 3.54B 158B P/E 2026 *
16.2x
P/E 2027 * 14.5x
Enterprise Value 4.57B 1.22B 1.07B 994M 914M 1.71B 118B 1.74B 11.88B 4.63B 57.45B 4.47B 199B EV / Sales 2026 *
2.81x
EV / Sales 2027 * 2.33x
Free-Float
78.97%
Yield 2026 *
1.97%
Yield 2027 * 3.3%
1 day-1.50%
1 week+0.40%
Current month+6.94%
1 month+4.21%
3 months-7.24%
6 months+8.55%
Current year+15.96%
1 week 28.6
Extreme 28.6
30.8
1 month 28.1
Extreme 28.1
30.8
Current year 24.96
Extreme 24.96
33.12
1 year 24
Extreme 24
33.12
3 years 20.94
Extreme 20.94
42.85
5 years 20.94
Extreme 20.94
61.4
10 years 20.94
Extreme 20.94
61.4
Manager TitleAgeSince
Chief Executive Officer 58 05/01/2021
Chief Executive Officer - 07/04/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 03/04/2016
Director/Board Member - 03/04/2019
Director/Board Member - 03/04/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%+0.40%+25.03%-23.10% 975M
+1.98%+1.69%+48.82%+158.83% 1,037B
+1.11%+3.26%+52.64%+50.87% 615B
+0.96%+0.61%+34.32%+78.76% 448B
+5.14%+5.40%+33.75%+27.79% 326B
+1.85%+3.57%+37.09%+40.59% 293B
-0.11%+0.48%+18.87%+17.70% 264B
+0.25%-4.62%-27.66%-41.76% 216B
+0.55%-0.97%+19.00%+56.30% 198B
-0.25%-4.77%+14.30%+67.14% 162B
Average +0.98%+1.23%+25.62%+43.31% 355.84B
Weighted average by Cap. +1.53%+1.47%+35.22%+75.83%

Financials

2026 *2027 *
Net sales 1.62B 433M 381M 354M 325M 610M 41.92B 621M 4.23B 1.65B 20.45B 1.59B 70.93B 1.92B 513M 451M 419M 385M 722M 49.65B 735M 5.01B 1.95B 24.22B 1.88B 84.01B
Net income 224M 59.8M 52.59M 48.86M 44.94M 84.27M 5.79B 85.78M 584M 228M 2.82B 220M 9.8B 253M 67.38M 59.26M 55.05M 50.63M 94.95M 6.52B 96.65M 658M 257M 3.18B 247M 11.04B
Net Debt 950M 253M 222M 207M 190M 356M 24.49B 363M 2.47B 964M 11.95B 929M 41.45B 863M 230M 202M 188M 173M 324M 22.26B 330M 2.25B 876M 10.86B 844M 37.66B
Logo Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC is a Saudi Arabia based pharmaceutical company. The Company is primarily engaged in manufacturing of pharmaceutical products, medicines for human use and wholesale and retail of medicines and related products, development and marketing of medical and pharmaceutical products, research and development in medical science activities, operating and maintaining the healthcare facilities and any investments in related industries. The Company is organized into four segments which include Pharmaceutical Manufacturing, Trading and Distribution Services, Healthcare Services and Discontinued Operation. Products of the Company include tablets, capsules, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Subsidiaries of the Company include ARACOM Medical Company, Dammam Pharmaceutical Company, SPIMACO Misr Company for Distribution and others.
Employees
-
Date Price Change Volume
23/07/26 SAR 30.22 -1.50% 315,942
22/07/26 SAR 30.68 +4.28% 865,006
21/07/26 SAR 29.42 +0.20% 171,383
20/07/26 SAR 29.36 +0.69% 264,102
19/07/26 SAR 29.16 -0.82% 182,138
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
30.22SAR
Average target price
31.86SAR
Spread / Average Target
+5.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2070 Stock